- Home
- NTIC vs ALGS Comparison
NTIC vs ALGS Comparison
Compare NTIC & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- ALGS
- Stock Information
- Founded
- NTIC 1970
- ALGS 2018
- Country
- NTIC United States
- ALGS United States
- Employees
- NTIC N/A
- ALGS N/A
- Industry
- NTIC Industrial Specialties
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- NTIC Industrials
- ALGS Health Care
- Exchange
- NTIC Nasdaq
- ALGS Nasdaq
- Market Cap
- NTIC 74.9M
- ALGS 72.6M
- IPO Year
- NTIC N/A
- ALGS 2020
- Fundamental
- Price
- NTIC $7.65
- ALGS $9.77
- Analyst Decision
- NTIC
- ALGS Strong Buy
- Analyst Count
- NTIC 0
- ALGS 2
- Target Price
- NTIC N/A
- ALGS $60.00
- AVG Volume (30 Days)
- NTIC 20.2K
- ALGS 94.0K
- Earning Date
- NTIC 11-18-2025
- ALGS 11-10-2025
- Dividend Yield
- NTIC 0.51%
- ALGS N/A
- EPS Growth
- NTIC N/A
- ALGS N/A
- EPS
- NTIC 0.31
- ALGS N/A
- Revenue
- NTIC $85,268,129.00
- ALGS $3,174,000.00
- Revenue This Year
- NTIC $1.09
- ALGS N/A
- Revenue Next Year
- NTIC $5.69
- ALGS N/A
- P/E Ratio
- NTIC $25.04
- ALGS N/A
- Revenue Growth
- NTIC 3.46
- ALGS N/A
- 52 Week Low
- NTIC $6.75
- ALGS $3.76
- 52 Week High
- NTIC $15.09
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- NTIC 51.91
- ALGS 47.57
- Support Level
- NTIC $7.40
- ALGS $9.25
- Resistance Level
- NTIC $7.92
- ALGS $10.89
- Average True Range (ATR)
- NTIC 0.22
- ALGS 0.80
- MACD
- NTIC -0.00
- ALGS -0.04
- Stochastic Oscillator
- NTIC 43.94
- ALGS 31.88
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.